Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Metabolomics | 35 | 2024 | 1658 | 4.690 |
Why?
|
Asthma | 39 | 2024 | 6230 | 3.250 |
Why?
|
Metabolome | 17 | 2024 | 989 | 2.270 |
Why?
|
Sphingolipids | 5 | 2023 | 173 | 1.150 |
Why?
|
Lymphoma, B-Cell | 4 | 2017 | 938 | 0.780 |
Why?
|
Vitamin D | 14 | 2024 | 3301 | 0.710 |
Why?
|
Lysine | 1 | 2024 | 982 | 0.650 |
Why?
|
Hypersensitivity, Immediate | 4 | 2023 | 348 | 0.630 |
Why?
|
Lymphoma, Follicular | 4 | 2015 | 457 | 0.630 |
Why?
|
Vitamins | 7 | 2024 | 1634 | 0.620 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2015 | 247 | 0.590 |
Why?
|
Chromosomes, Human, Pair 14 | 2 | 2015 | 286 | 0.590 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2023 | 2517 | 0.580 |
Why?
|
Health | 1 | 2020 | 398 | 0.570 |
Why?
|
Cadmium | 2 | 2018 | 215 | 0.550 |
Why?
|
Vulnerable Populations | 1 | 2022 | 706 | 0.550 |
Why?
|
Hydrocarbons, Chlorinated | 1 | 2017 | 121 | 0.520 |
Why?
|
Lung | 5 | 2024 | 9979 | 0.500 |
Why?
|
Immunoglobulin E | 5 | 2024 | 1505 | 0.490 |
Why?
|
Respiratory Sounds | 8 | 2024 | 702 | 0.480 |
Why?
|
Cholecalciferol | 1 | 2019 | 552 | 0.470 |
Why?
|
Food Hypersensitivity | 4 | 2024 | 726 | 0.440 |
Why?
|
Carcinogens | 2 | 2018 | 452 | 0.430 |
Why?
|
Translocation, Genetic | 2 | 2015 | 1391 | 0.410 |
Why?
|
Lead | 2 | 2018 | 879 | 0.400 |
Why?
|
Hypersensitivity | 4 | 2023 | 1167 | 0.390 |
Why?
|
Environmental Pollutants | 2 | 2023 | 1276 | 0.390 |
Why?
|
Pregnancy | 26 | 2024 | 29893 | 0.380 |
Why?
|
Bacteremia | 1 | 2018 | 978 | 0.370 |
Why?
|
Costa Rica | 4 | 2019 | 180 | 0.370 |
Why?
|
Chromatography, Liquid | 5 | 2023 | 982 | 0.340 |
Why?
|
Interleukin-8 | 2 | 2022 | 696 | 0.330 |
Why?
|
Vital Capacity | 3 | 2021 | 970 | 0.330 |
Why?
|
Humans | 104 | 2024 | 761208 | 0.320 |
Why?
|
Adrenal Cortex Hormones | 4 | 2023 | 1878 | 0.320 |
Why?
|
Italy | 5 | 2019 | 844 | 0.310 |
Why?
|
Respiratory Function Tests | 4 | 2021 | 1685 | 0.310 |
Why?
|
Eczema | 2 | 2022 | 246 | 0.310 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 6 | 2019 | 1640 | 0.300 |
Why?
|
Sweden | 5 | 2021 | 1379 | 0.300 |
Why?
|
Child | 30 | 2024 | 80152 | 0.290 |
Why?
|
Vitamin D Deficiency | 3 | 2024 | 1388 | 0.290 |
Why?
|
Child, Preschool | 23 | 2024 | 42224 | 0.280 |
Why?
|
Lipids | 4 | 2023 | 3331 | 0.280 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2014 | 1372 | 0.280 |
Why?
|
Female | 64 | 2024 | 392544 | 0.280 |
Why?
|
Bronchodilator Agents | 2 | 2021 | 512 | 0.270 |
Why?
|
Ejaculation | 2 | 2016 | 59 | 0.260 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2023 | 15920 | 0.260 |
Why?
|
Male | 54 | 2024 | 360693 | 0.250 |
Why?
|
Eicosanoids | 2 | 2024 | 282 | 0.250 |
Why?
|
Forced Expiratory Volume | 2 | 2021 | 1813 | 0.250 |
Why?
|
Premature Birth | 3 | 2022 | 1784 | 0.250 |
Why?
|
Membrane Proteins | 3 | 2019 | 7851 | 0.250 |
Why?
|
Mass Spectrometry | 5 | 2019 | 2189 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 8530 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 10 | 2023 | 17897 | 0.240 |
Why?
|
Erythrocytes | 1 | 2013 | 2413 | 0.230 |
Why?
|
Case-Control Studies | 12 | 2020 | 22174 | 0.230 |
Why?
|
Macular Degeneration | 2 | 2024 | 1008 | 0.230 |
Why?
|
Exercise | 1 | 2020 | 5874 | 0.220 |
Why?
|
Prostatic Neoplasms | 5 | 2017 | 11101 | 0.220 |
Why?
|
Carnitine | 1 | 2024 | 252 | 0.210 |
Why?
|
Air Pollution | 3 | 2021 | 2351 | 0.210 |
Why?
|
Genome-Wide Association Study | 12 | 2023 | 12676 | 0.210 |
Why?
|
Prospective Studies | 22 | 2023 | 54435 | 0.210 |
Why?
|
Diabetes, Gestational | 2 | 2022 | 1250 | 0.200 |
Why?
|
Genotype | 8 | 2023 | 12985 | 0.200 |
Why?
|
C-Reactive Protein | 3 | 2022 | 3821 | 0.200 |
Why?
|
RNA, Ribosomal, 16S | 3 | 2023 | 1032 | 0.200 |
Why?
|
Inflammation | 4 | 2022 | 10759 | 0.190 |
Why?
|
Environmental Exposure | 6 | 2021 | 4479 | 0.190 |
Why?
|
Biological Therapy | 1 | 2022 | 139 | 0.180 |
Why?
|
Infant | 14 | 2024 | 36169 | 0.180 |
Why?
|
Alkanesulfonic Acids | 1 | 2023 | 201 | 0.180 |
Why?
|
Medically Underserved Area | 1 | 2022 | 254 | 0.170 |
Why?
|
Pregnancy Trimester, Third | 1 | 2022 | 583 | 0.170 |
Why?
|
Body Mass Index | 5 | 2024 | 12952 | 0.170 |
Why?
|
Epidemiology | 2 | 2019 | 280 | 0.170 |
Why?
|
Gene Regulatory Networks | 2 | 2018 | 1743 | 0.170 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 323 | 0.170 |
Why?
|
Academies and Institutes | 1 | 2022 | 318 | 0.170 |
Why?
|
BCG Vaccine | 1 | 2022 | 369 | 0.160 |
Why?
|
Ethanolamines | 1 | 2019 | 153 | 0.160 |
Why?
|
Cohort Studies | 13 | 2024 | 41496 | 0.160 |
Why?
|
Multiple Myeloma | 2 | 2014 | 5145 | 0.160 |
Why?
|
Desensitization, Immunologic | 1 | 2024 | 557 | 0.160 |
Why?
|
Dietary Supplements | 4 | 2024 | 3410 | 0.160 |
Why?
|
Alleles | 3 | 2019 | 6857 | 0.160 |
Why?
|
Food Supply | 1 | 2024 | 539 | 0.160 |
Why?
|
Epidemiologic Studies | 1 | 2022 | 677 | 0.150 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2019 | 418 | 0.150 |
Why?
|
Education | 1 | 2021 | 536 | 0.150 |
Why?
|
Interferon Regulatory Factors | 1 | 2019 | 261 | 0.150 |
Why?
|
Caffeine | 1 | 2022 | 701 | 0.150 |
Why?
|
Nitrogen Dioxide | 1 | 2021 | 521 | 0.150 |
Why?
|
Research Report | 1 | 2021 | 367 | 0.150 |
Why?
|
Eosinophils | 2 | 2023 | 951 | 0.150 |
Why?
|
Depression, Postpartum | 1 | 2022 | 349 | 0.150 |
Why?
|
Pharmacogenetics | 1 | 2021 | 675 | 0.150 |
Why?
|
Phenotype | 4 | 2023 | 16575 | 0.140 |
Why?
|
Fluorocarbons | 1 | 2023 | 492 | 0.140 |
Why?
|
Puerto Rico | 3 | 2024 | 378 | 0.140 |
Why?
|
Sphingosine | 1 | 2019 | 307 | 0.140 |
Why?
|
Epidemiologic Methods | 2 | 2019 | 1336 | 0.140 |
Why?
|
Lysophospholipids | 1 | 2019 | 337 | 0.140 |
Why?
|
RNA, Bacterial | 1 | 2019 | 393 | 0.140 |
Why?
|
Cell Wall | 1 | 2020 | 417 | 0.140 |
Why?
|
Candida albicans | 1 | 2020 | 372 | 0.140 |
Why?
|
Polychlorinated Biphenyls | 1 | 2019 | 236 | 0.140 |
Why?
|
Quantitative Trait Loci | 2 | 2023 | 2113 | 0.140 |
Why?
|
Air Pollutants | 2 | 2021 | 2889 | 0.140 |
Why?
|
Dermatitis, Atopic | 1 | 2024 | 731 | 0.140 |
Why?
|
Body Burden | 1 | 2017 | 158 | 0.140 |
Why?
|
Computational Biology | 5 | 2021 | 3499 | 0.130 |
Why?
|
Phosphates | 1 | 2020 | 763 | 0.130 |
Why?
|
Middle Aged | 27 | 2024 | 220853 | 0.130 |
Why?
|
Fungal Proteins | 1 | 2020 | 908 | 0.130 |
Why?
|
Androgens | 1 | 2023 | 1283 | 0.130 |
Why?
|
Fish Oils | 1 | 2019 | 483 | 0.130 |
Why?
|
Citric Acid Cycle | 1 | 2016 | 231 | 0.120 |
Why?
|
Infant, Newborn | 8 | 2024 | 26199 | 0.120 |
Why?
|
Breath Tests | 1 | 2016 | 299 | 0.120 |
Why?
|
Wet Macular Degeneration | 1 | 2017 | 162 | 0.120 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2018 | 540 | 0.120 |
Why?
|
Communicable Diseases | 1 | 2023 | 873 | 0.120 |
Why?
|
Receptors, Adiponectin | 1 | 2015 | 81 | 0.120 |
Why?
|
Anti-Asthmatic Agents | 1 | 2020 | 573 | 0.120 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20119 | 0.120 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2020 | 725 | 0.120 |
Why?
|
Cryopreservation | 1 | 2020 | 728 | 0.120 |
Why?
|
Adolescent | 11 | 2024 | 88298 | 0.120 |
Why?
|
Genetic Loci | 2 | 2014 | 2623 | 0.120 |
Why?
|
Adult | 24 | 2022 | 221119 | 0.110 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 780 | 0.110 |
Why?
|
Linear Models | 1 | 2024 | 5869 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2023 | 1390 | 0.110 |
Why?
|
Risk Factors | 13 | 2024 | 74239 | 0.110 |
Why?
|
Leukemia, Lymphoid | 1 | 2013 | 311 | 0.110 |
Why?
|
Lung Diseases | 2 | 2021 | 1910 | 0.110 |
Why?
|
B-Lymphocyte Subsets | 1 | 2014 | 238 | 0.110 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 178 | 0.110 |
Why?
|
Administration, Inhalation | 3 | 2022 | 1159 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 2019 | 1603 | 0.110 |
Why?
|
Receptors, IgE | 1 | 2014 | 375 | 0.110 |
Why?
|
NFATC Transcription Factors | 1 | 2015 | 390 | 0.110 |
Why?
|
DNA Methylation | 2 | 2019 | 4384 | 0.100 |
Why?
|
Autistic Disorder | 1 | 2022 | 1222 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2021 | 1160 | 0.100 |
Why?
|
Lipid Metabolism | 2 | 2022 | 1893 | 0.100 |
Why?
|
Chromosomes, Human | 1 | 2014 | 442 | 0.100 |
Why?
|
Influenza, Human | 1 | 2023 | 1521 | 0.100 |
Why?
|
Particulate Matter | 2 | 2021 | 2597 | 0.100 |
Why?
|
Major Histocompatibility Complex | 1 | 2015 | 872 | 0.100 |
Why?
|
Prenatal Care | 1 | 2019 | 1141 | 0.100 |
Why?
|
Neoplasms | 2 | 2018 | 22140 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1510 | 0.090 |
Why?
|
Polymerase Chain Reaction | 2 | 2018 | 6067 | 0.090 |
Why?
|
Aged | 21 | 2024 | 169288 | 0.090 |
Why?
|
Lymphoproliferative Disorders | 1 | 2014 | 531 | 0.090 |
Why?
|
Leukemia, Myeloid | 1 | 2013 | 693 | 0.090 |
Why?
|
Dietary Fats | 1 | 2018 | 1994 | 0.090 |
Why?
|
Infant, Premature | 1 | 2020 | 2106 | 0.090 |
Why?
|
Environmental Monitoring | 1 | 2017 | 1460 | 0.090 |
Why?
|
Tryptophan | 2 | 2024 | 480 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8003 | 0.090 |
Why?
|
Telomere | 1 | 2016 | 939 | 0.080 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1225 | 0.080 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12474 | 0.080 |
Why?
|
Gene Expression | 2 | 2020 | 7571 | 0.080 |
Why?
|
Tuberculosis | 1 | 2022 | 2016 | 0.080 |
Why?
|
HLA Antigens | 1 | 2014 | 1331 | 0.080 |
Why?
|
Odds Ratio | 2 | 2018 | 9652 | 0.080 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2019 | 1462 | 0.080 |
Why?
|
Genetic Markers | 1 | 2014 | 2599 | 0.070 |
Why?
|
Bacteria | 1 | 2019 | 2190 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 1404 | 0.070 |
Why?
|
MicroRNAs | 1 | 2024 | 3758 | 0.070 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1405 | 0.070 |
Why?
|
Depression | 2 | 2024 | 8132 | 0.070 |
Why?
|
Tandem Mass Spectrometry | 2 | 2023 | 1186 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3707 | 0.070 |
Why?
|
Metabolic Networks and Pathways | 2 | 2024 | 790 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2731 | 0.070 |
Why?
|
Social Class | 1 | 2015 | 1993 | 0.070 |
Why?
|
Allergens | 2 | 2024 | 1433 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2018 | 3044 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11856 | 0.060 |
Why?
|
Cell Line | 1 | 2019 | 15545 | 0.060 |
Why?
|
Chromatin | 1 | 2017 | 2946 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3434 | 0.060 |
Why?
|
Oxidative Stress | 1 | 2016 | 3114 | 0.060 |
Why?
|
Lymphoma | 1 | 2014 | 1898 | 0.060 |
Why?
|
Communication | 1 | 2019 | 3872 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9416 | 0.060 |
Why?
|
Portugal | 1 | 2024 | 91 | 0.060 |
Why?
|
Young Adult | 9 | 2022 | 59221 | 0.060 |
Why?
|
Temperature | 2 | 2021 | 2219 | 0.060 |
Why?
|
Risk | 4 | 2019 | 9616 | 0.060 |
Why?
|
Proteomics | 1 | 2017 | 3840 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3696 | 0.060 |
Why?
|
Feces | 2 | 2022 | 1490 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2024 | 64681 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2949 | 0.050 |
Why?
|
Ontario | 1 | 2024 | 398 | 0.050 |
Why?
|
Sphingomyelins | 1 | 2023 | 105 | 0.050 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2023 | 88 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10218 | 0.050 |
Why?
|
Cell Movement | 1 | 2014 | 5195 | 0.050 |
Why?
|
Fatty Acids | 2 | 2023 | 1807 | 0.050 |
Why?
|
Age Factors | 4 | 2021 | 18384 | 0.050 |
Why?
|
Ceramides | 1 | 2023 | 200 | 0.050 |
Why?
|
Immunologic Tests | 1 | 2023 | 104 | 0.050 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 394 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 6988 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2022 | 12341 | 0.050 |
Why?
|
Software Design | 1 | 2022 | 172 | 0.050 |
Why?
|
Feeding Behavior | 1 | 2013 | 3183 | 0.050 |
Why?
|
Prevalence | 2 | 2015 | 15721 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5842 | 0.050 |
Why?
|
Albuterol | 1 | 2021 | 211 | 0.050 |
Why?
|
Prognosis | 3 | 2016 | 29687 | 0.040 |
Why?
|
Immunomodulation | 1 | 2024 | 548 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2024 | 58952 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15520 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39126 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2021 | 348 | 0.040 |
Why?
|
Fatty Acids, Volatile | 1 | 2019 | 103 | 0.040 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2019 | 189 | 0.040 |
Why?
|
ADAM Proteins | 1 | 2020 | 238 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2021 | 737 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2022 | 908 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2019 | 239 | 0.040 |
Why?
|
Milk, Human | 1 | 2022 | 486 | 0.040 |
Why?
|
Allergy and Immunology | 1 | 2019 | 177 | 0.040 |
Why?
|
Obesity | 2 | 2017 | 12939 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9278 | 0.040 |
Why?
|
Problem Solving | 1 | 2020 | 443 | 0.040 |
Why?
|
Colorado | 1 | 2017 | 165 | 0.040 |
Why?
|
Spirometry | 1 | 2021 | 928 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 12159 | 0.040 |
Why?
|
Europe | 2 | 2014 | 3423 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 988 | 0.030 |
Why?
|
Amino Acids | 1 | 2023 | 1703 | 0.030 |
Why?
|
Benchmarking | 1 | 2023 | 1045 | 0.030 |
Why?
|
Bacteroides fragilis | 1 | 2018 | 250 | 0.030 |
Why?
|
Administration, Oral | 1 | 2024 | 4015 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 1 | 2018 | 461 | 0.030 |
Why?
|
Amines | 1 | 2017 | 280 | 0.030 |
Why?
|
Prostate-Specific Antigen | 2 | 2016 | 2465 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26071 | 0.030 |
Why?
|
Drug Discovery | 1 | 2023 | 1050 | 0.030 |
Why?
|
Fetus | 1 | 2023 | 1864 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2024 | 2307 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2020 | 716 | 0.030 |
Why?
|
Educational Status | 1 | 2022 | 2510 | 0.030 |
Why?
|
Natural Killer T-Cells | 1 | 2018 | 322 | 0.030 |
Why?
|
Kallikreins | 1 | 2016 | 220 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2024 | 2092 | 0.030 |
Why?
|
Serpins | 1 | 2016 | 247 | 0.030 |
Why?
|
Eosinophilia | 1 | 2018 | 557 | 0.030 |
Why?
|
DNA Replication | 1 | 2021 | 1415 | 0.030 |
Why?
|
Systems Biology | 1 | 2017 | 481 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14610 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 550 | 0.030 |
Why?
|
Cesarean Section | 1 | 2022 | 1399 | 0.030 |
Why?
|
Meat Products | 1 | 2013 | 96 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2016 | 469 | 0.030 |
Why?
|
Diet, Mediterranean | 1 | 2020 | 738 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2015 | 628 | 0.030 |
Why?
|
Family | 1 | 2024 | 3192 | 0.030 |
Why?
|
Cytidine Deaminase | 1 | 2014 | 242 | 0.030 |
Why?
|
Poverty | 1 | 2024 | 2691 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2017 | 803 | 0.030 |
Why?
|
Mothers | 1 | 2023 | 2193 | 0.030 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2013 | 313 | 0.020 |
Why?
|
Molecular Epidemiology | 1 | 2014 | 470 | 0.020 |
Why?
|
Nuts | 1 | 2013 | 264 | 0.020 |
Why?
|
Boston | 1 | 2024 | 9327 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 991 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20982 | 0.020 |
Why?
|
Child Development | 1 | 2023 | 2302 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2016 | 1141 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2017 | 1791 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2013 | 727 | 0.020 |
Why?
|
Dairy Products | 1 | 2013 | 490 | 0.020 |
Why?
|
Social Environment | 1 | 2015 | 1022 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5778 | 0.020 |
Why?
|
Osteosarcoma | 1 | 2015 | 896 | 0.020 |
Why?
|
Internet | 1 | 2022 | 3096 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 801 | 0.020 |
Why?
|
Adiponectin | 1 | 2015 | 1107 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 21365 | 0.020 |
Why?
|
Prostate | 1 | 2017 | 1772 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2020 | 2974 | 0.020 |
Why?
|
United States | 3 | 2024 | 72339 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1885 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2013 | 1518 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2013 | 1994 | 0.020 |
Why?
|
Haplotypes | 1 | 2014 | 2715 | 0.020 |
Why?
|
Fruit | 1 | 2013 | 1158 | 0.020 |
Why?
|
Vegetables | 1 | 2013 | 1192 | 0.020 |
Why?
|
Health Behavior | 1 | 2019 | 2641 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2017 | 3770 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 7046 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2014 | 4612 | 0.020 |
Why?
|
Overweight | 1 | 2017 | 2418 | 0.020 |
Why?
|
Energy Intake | 1 | 2013 | 2133 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6567 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3923 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2897 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7804 | 0.020 |
Why?
|
Nutritional Status | 1 | 2013 | 1597 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2636 | 0.010 |
Why?
|
Biopsy | 1 | 2016 | 6781 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4513 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2527 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2015 | 2223 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9566 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13249 | 0.010 |
Why?
|
Mice | 2 | 2023 | 81326 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9520 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12052 | 0.010 |
Why?
|
Algorithms | 1 | 2022 | 14025 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4744 | 0.010 |
Why?
|
Transcription Factors | 1 | 2020 | 12099 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7865 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10707 | 0.010 |
Why?
|
Aging | 1 | 2018 | 8702 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15841 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10422 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9477 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4251 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 9055 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13511 | 0.010 |
Why?
|
Animals | 2 | 2023 | 168079 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 39957 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 24021 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13385 | 0.010 |
Why?
|